# Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies

> **NCT05203809** · — · UNKNOWN · sponsor: **Malaghan Institute of Medical Research** · enrollment: 20 (estimated)

## Conditions studied

- Haematological Malignancy
- Leukemia
- Lymphoma
- Myeloma
- Temperature Change, Body

## Interventions

- **DEVICE:** TempTraq temperature monitor

## Key facts

- **NCT ID:** NCT05203809
- **Lead sponsor:** Malaghan Institute of Medical Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-18
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05203809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05203809, "Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05203809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*